Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
AMITSUR'S CONJECTURE FOR POLYNOMIAL H-IDENTITIES OF H-MODULE LIE ALGEBRAS
AMITIFADINE HYDROCHLORIDE Triple Reuptake Inhibitor Treatment of Depression
AMI伴束支阻滞的多面性与临床意义
AMI病人冠状动脉内支架安置术的无复流现象分析
AMI泵衰竭20例分析
AMI伴对应性ST段压低的核素心血池显像观察
AMI并泵衰竭PCI后患者主动脉球囊反搏并呼吸机的疗效
AMI出院患者自我管理行为及影响因素调查
AMI重症患者急诊PCI围手术期行辅助循环支持的临床研究
AMI大鼠Ghrelin的变化及人Ghrelin对其影响
AMI冠脉未通肌酸激酶MB蛋白的诊断价值
AMI梗死相关血管与氮末端脑钠素前体水平的相关性研究
AMI改性白炭黑填充SBR的性能研究
AMI患者早期心电图ST段抬高的临床意义
AMI患者血浆BNP、ET-1升高与发生血流动力学障碍的相关性研究
AMI患者循环内皮细胞核DNA特点及copeptin测定的临床价值
AMI患者血浆NT-proBNP含量的变化及其与心功能的相关性研究
AMI患者血浆NT-proBNP前体水平与梗死部位的关系及比索洛尔的干预效应
AMI患者血浆NT-proBNP水平与心肌缺血及预后关系的研究
AMI患者急诊经皮冠状动脉介入术116例护理
AMI患者PWV与颈动脉IMT的相关性研究
AMI患者血清NT-ProBNP与心肌酶水平的相关性研究
AMI后血清中锌、铜、钼、钙、磷的变化
AMI患者行急诊CPI术后个体护理干预效果分析
AMI患者血浆BNP的水平与组织纤维化血清指标关系的研究
AMI患者急性期的“治疗性”语言干预
AMI患者治疗前后血浆BNP、ANP、CKMB的变化及其临床意义
AMI患者血液流变学检测的临床分析
AMI患者PCI后心肌灌注水平对心功能及左室重构的影响
AMI患者循环内皮细胞核DNA特点及copeptin测定的临床价值
AMI患者PCI术后校正TIMI帧数与梗死区域心肌组织收缩功能的影响
AMI后心力衰竭应用不同剂量培哚普利的疗效及对NT-proBNP及心肌能量消耗的影响
AMI患者血清前白蛋白与炎症因子、血脂的相关性
AMI急诊PCI术后心肌活动指数对心力衰竭的预测价值
AMI溶栓后不同程度冠状动脉狭窄与HRV的关系及临床意义
AMI溶栓治疗前后血浆内皮素的动态变化
AMI数据分析方法
AMI通信网络中微功率无线通信的性能测试技术及系统研究
AMI危重症患者应用主动脉内球囊反搏辅助治疗的预后观察
AMI系统下塑料光纤通信技术应用探讨
AMI系统中高容量资源管理策略
AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model
AML cells carrying NPM1 mutation are resistant to nucleophosmin displacement from nucleoli caused by the G-quadruplex ligand TmPyP4
AML sensitivity to YM155 is modulated through AKT and Mcl-1
AML evolution from preleukemia to leukemia and relapse
AML treatment in older adults
AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3
AML multi-gene panel testing: A review and comparison of two gene panels
AML Genomics for the Clinician
AML BLASTS VARIABLY EXPRESS INTERLEUKIN-2 RECEPTOR-ALPHA-CHAINS, BETA-CHAINS OR GAMMA-CHAINS WITHOUT MEASURABLE EFFECTS ON PROLIFERATION, CYTOKINE MESSAGE EXPRESSION OR SURFACE EXPRESSION OF ADHESION MOLECULES UPON STIMULATION WITH INTERLEUKIN-2
AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions
AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features
AML in older patients: Are we making progress?
AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16(INK4A) mRNA with prognostic significance
AML in 2016: Where we are now?
AML cytogenetics: the complex just got simpler
AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis
AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB
AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses
AML versus ICU: outcome of septic AML patients in an intensive care setting
AML in 2017: Advances in clinical practice
AML,MAL及RAEB-2中Auer小体检出率及其形态学观察
AML-2车载激光雷达测量臭氧的大气后向散射系数项修正方法研究
AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses
AML/TMDS与MDS-AML的对比研究
AML/MDS with 11q/MLL Amplification Show Characteristic Gene Expression Signature and Interplay of DNA Copy Number Changes
AML1 mutations induced MDS and MDS/AML in a mouse BMT model
AML1-ETO融合蛋白对BCL-2基因表达的影响
AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia
AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX/beta-catenin signaling pathway
AML1-ETO转基因小鼠的建立及初步表型分析
AML1/ETO阳性急性髓系白血病患者FLT3基因高表达及其临床意义
AML1-ETO融合蛋白致细胞转化的分子机制
AML1/ETO Proteins Control POU4F1/BRN3A Expression and Function in t(8;21) Acute Myeloid Leukemia
AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2(V617F)-independent overexpression of NF-E2
AML1 enhances the expression of leukotriene B-4 type-1 receptor in leukocytes
AML1-ETO阳性急性髓系白血病预后影响因素的研究进展
AML1-ETO阳性的儿童急性髓系白血病的诊治分析
AML1-ETO融合蛋白致急性髓系白血病机制及靶向治疗
AML1/ETO and POU4F1 synergy drives B-lymphoid gene expression typical of t(8;21) acute myeloid leukemia
AML1/RUNX1 functions as a cytoplasmic attenuator of NF-kappa B signaling in the repression of myeloid tumors
AML1/RUNX1 increases during G(1) to S cell cycle progression independent of cytokine-dependent phosphorylation and induces cyclin D3 gene expression
AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complex